Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bionano Genomics Q1 EPS $(1.15) Beats $(3.02) Estimate, Sales $6.50M Beat $6.23M Estimate

Author: Benzinga Newsdesk | May 14, 2025 04:14pm
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.15) per share which beat the analyst consensus estimate of $(3.02) by 61.92 percent. This is a 96.78 percent increase over losses of $(35.75) per share from the same period last year. The company reported quarterly sales of $6.50 million which beat the analyst consensus estimate of $6.23 million by 4.28 percent. This is a 25.88 percent decrease over sales of $8.77 million the same period last year.

Posted In: BNGO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist